This study aimed to evaluate the benefit of a Radiomics-based model including quantitative morphological and metabolic information of PET-CT for predicting the response and survival of treatment-naïve patients with advanced NSCLC undergoing treatment with either CKI-monotherapy or CKI in combination with chemotherapy. The gene discussed is CHKA; the disease is non-small cell lung carcinoma.